These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 34850006)

  • 21. Glycated Hemoglobin as a First-line Screening Test for Cystic Fibrosis‒Related Diabetes and Impaired Glucose Tolerance in Children With Cystic Fibrosis: A Validation Study.
    Racine F; Shohoudi A; Boudreau V; Nguyen CQT; Denis MH; Desjardins K; Reynaud Q; Rabasa-Lhoret R; Mailhot G
    Can J Diabetes; 2021 Dec; 45(8):768-774. PubMed ID: 33926819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HbA1c as a screening tool for cystic fibrosis related diabetes.
    Burgess JC; Bridges N; Banya W; Gyi KM; Hodson ME; Bilton D; Simmonds NJ
    J Cyst Fibros; 2016 Mar; 15(2):251-7. PubMed ID: 25869326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug treatments for managing cystic fibrosis-related diabetes.
    Onady GM; Stolfi A
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD004730. PubMed ID: 33075159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis of cystic fibrosis related diabetes: a selective approach in performing the oral glucose tolerance test based on a combination of clinical and biochemical criteria.
    Yung B; Kemp M; Hooper J; Hodson ME
    Thorax; 1999 Jan; 54(1):40-3. PubMed ID: 10343630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Laffel LM; Kanapka LG; Beck RW; Bergamo K; Clements MA; Criego A; DeSalvo DJ; Goland R; Hood K; Liljenquist D; Messer LH; Monzavi R; Mouse TJ; Prahalad P; Sherr J; Simmons JH; Wadwa RP; Weinstock RS; Willi SM; Miller KM; ;
    JAMA; 2020 Jun; 323(23):2388-2396. PubMed ID: 32543683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The course of glucose intolerance in children with cystic fibrosis: a retrospective study - preliminary report.
    Piechowiak K; Trippenbach-Dulska H; Walicka-Serzysko K
    Dev Period Med; 2015; 19(1):80-91. PubMed ID: 26003073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes.
    Chan CL; Pyle L; Kelsey MM; Newnes L; Baumgartner A; Zeitler PS; Nadeau KJ
    Pediatr Diabetes; 2017 Nov; 18(7):629-636. PubMed ID: 27873436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoglycemia is common in children with cystic fibrosis and seen predominantly in females.
    Haliloglu B; Gokdemir Y; Atay Z; Abali S; Guran T; Karakoc F; Ersu R; Karadag B; Turan S; Bereket A
    Pediatr Diabetes; 2017 Nov; 18(7):607-613. PubMed ID: 27873431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormal glucose tolerance in children with cystic fibrosis: the predictive role of continuous glucose monitoring system.
    Schiaffini R; Brufani C; Russo B; Fintini D; Migliaccio A; Pecorelli L; Bizzarri C; Lucidi V; Cappa M
    Eur J Endocrinol; 2010 Apr; 162(4):705-10. PubMed ID: 20071479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous glucose monitoring and its relationship to hemoglobin A1c and oral glucose tolerance testing in obese and prediabetic youth.
    Chan CL; Pyle L; Newnes L; Nadeau KJ; Zeitler PS; Kelsey MM
    J Clin Endocrinol Metab; 2015 Mar; 100(3):902-10. PubMed ID: 25532041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of hyperglycemia in cystic fibrosis pulmonary exacerbations.
    Merjaneh L; Sidhaye AR; Vu PT; Heltshe SL; Goss CH; Flume PA; Kelly A; Rosenfeld M
    J Cyst Fibros; 2023 Sep; 22(5):868-874. PubMed ID: 37394317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
    Beck RW; Riddlesworth T; Ruedy K; Ahmann A; Bergenstal R; Haller S; Kollman C; Kruger D; McGill JB; Polonsky W; Toschi E; Wolpert H; Price D;
    JAMA; 2017 Jan; 317(4):371-378. PubMed ID: 28118453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cystic Fibrosis-Related Diabetes Screening in Adults: A Gap Analysis and Evaluation of Accuracy of Glycated Hemoglobin Levels.
    Gilmour JA; Sykes J; Etchells E; Tullis E
    Can J Diabetes; 2019 Feb; 43(1):13-18. PubMed ID: 30173928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycemic Variability and the Thickness of Retinal Layers in Cystic Fibrosis Patients with and without Cystic Fibrosis Related Diabetes.
    Saegebrecht LS; Röhlig M; Schaub F; Ballmann M; Stachs O; Fischer DC
    Curr Eye Res; 2024 Jul; 49(7):759-767. PubMed ID: 38557392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis].
    Khammar A; Stremler N; Dubus JC; Gross G; Sarles J; Reynaud R
    Arch Pediatr; 2009 Dec; 16(12):1540-6. PubMed ID: 19854630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of CGM-Derived Measures of Glycemic Variability Between Pancreatogenic Diabetes and Type 2 Diabetes Mellitus.
    Shivaprasad C; Aiswarya Y; Kejal S; Sridevi A; Anupam B; Ramdas B; Gautham K; Aarudhra P
    J Diabetes Sci Technol; 2021 Jan; 15(1):134-140. PubMed ID: 31282179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early glucose abnormalities revealed by continuous glucose monitoring associate with lung function decline in cystic fibrosis: A five-year prospective study.
    Rakotoarisoa L; Weiss L; Lefebvre F; Porzio M; Renaud-Picard B; Ravoninjatovo B; Abely M; Danner-Boucher I; Dubois S; Troussier F; Prevotat A; Rault G; Kessler R; Kessler L
    J Diabetes Complications; 2024 Apr; 38(4):108703. PubMed ID: 38430625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Pratley RE; Kanapka LG; Rickels MR; Ahmann A; Aleppo G; Beck R; Bhargava A; Bode BW; Carlson A; Chaytor NS; Fox DS; Goland R; Hirsch IB; Kruger D; Kudva YC; Levy C; McGill JB; Peters A; Philipson L; Philis-Tsimikas A; Pop-Busui R; Shah VN; Thompson M; Vendrame F; Verdejo A; Weinstock RS; Young L; Miller KM;
    JAMA; 2020 Jun; 323(23):2397-2406. PubMed ID: 32543682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycated hemoglobin cannot yet be proposed as a screening tool for cystic fibrosis related diabetes.
    Boudreau V; Coriati A; Desjardins K; Rabasa-Lhoret R
    J Cyst Fibros; 2016 Mar; 15(2):258-60. PubMed ID: 26905501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuous Glucose Monitoring as an Additional Tool in Early Cystic Fibrosis-Related Diabetes Monitoring and in Evaluation of Short-Term Sitagliptin Response.
    Sebastian-Valles F; Arranz Martín JA; Girón RM; Knott-Torcal C; Sampedro-Nuñez MA; Martin-Adan JC; Jiménez-Díaz J; Marazuela M
    Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.